LL-37
ResearchLL-37 (Cathelicidin Antimicrobial Peptide)
- Category
- Immune & Inflammatory
- Aliases
- hCAP-18 fragment, Cathelicidin
- Administration
- Topical (research), Subcutaneous injection (research)
Research and regulatory
Development stage
Extensively studied preclinically for antimicrobial and wound-healing properties; early-phase research for topical/wound applications.
Legal and regulatory
Unscheduled research compound; not FDA approved.
Side effects
Limited data on human side effects; topical irritation possible